Dr. Mark de Wolde Dvm Mrcvs

Dr. Mark de Wolde DVM MRCVS is a distinguished veterinary professional with extensive experience in leadership and consultancy roles. As Co-Founder and Chief Veterinary Officer of NerveX and Co-Founder and Medical Director of myVETgroup, Dr. de Wolde has significantly contributed to veterinary practice innovation. Dr. de Wolde also serves as President of Lenio Pharmaceuticals Inc. and as a Veterinary Consultant for DrugSmart Pharmacy Group. Additionally, involvement as a mentor for the Scotiabank Women's Initiative through The Forum highlights a commitment to supporting emerging leaders in the field. Dr. de Wolde holds a Doctor of Veterinary Medicine degree from Ontario Veterinary College, University of Guelph, and has furthered education at Utrecht University.